Literature DB >> 24535164

CNS cancer: new options for glioblastoma.

Alessia Errico.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24535164     DOI： 10.1038/nrclinonc.2014.27

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  2 in total

1.  Mathematical modeling of PDGF-driven glioblastoma reveals optimized radiation dosing schedules.

Authors:  Kevin Leder; Ken Pitter; Quincey LaPlant; Dolores Hambardzumyan; Brian D Ross; Timothy A Chan; Eric C Holland; Franziska Michor
Journal:  Cell       Date:  2014-01-30       Impact factor: 41.582

2.  Stage-specific embryonic antigen-4 as a potential therapeutic target in glioblastoma multiforme and other cancers.

Authors:  Yi-Wei Lou; Pao-Yuan Wang; Shih-Chi Yeh; Po-Kai Chuang; Shiou-Ting Li; Chung-Yi Wu; Kay-Hooi Khoo; Michael Hsiao; Tsui-Ling Hsu; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205
  2 in total
  2 in total

1.  GDNF Promotes Astrocyte Abnormal Proliferation and Migration Through the GFRα1/RET/MAPK/pCREB/LOXL2 Signaling Axis.

Authors:  Miaomiao Wang; Xiao Han; Wei Zha; Xiaoyu Wang; Liyun Liu; Zimu Li; Yefeng Shi; Xugang Kan; Gui Wang; Dianshuai Gao; Baole Zhang
Journal:  Mol Neurobiol       Date:  2022-08-04       Impact factor: 5.682

2.  Novel read-through fusion transcript Bcl2l2-Pabpn1 in glioblastoma cells.

Authors:  Lin Zhang; Dan Wang; Xiao Han; Xiaoxiao Guo; Yuanyuan Cao; Ying Xia; Dianshuai Gao
Journal:  J Cell Mol Med       Date:  2022-07-27       Impact factor: 5.295
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.